EURONEXT:ABNX
ABIONYX Pharma SA
- Stock
Last Close
1.28
30/08 15:14
Market Cap
39.38M
Beta: 0.27
Volume Today
6.31K
Avg: 123.73K
PE Ratio
−7.77
PFCF: −10.89
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 174K - | 675K - | 5.25M 678.07% | 4.60M 12.41% | ||||||||
cost of revenue | 72K - | 80K 11.11% | 416K 420% | 4.62M 1,009.62% | 4M 13.34% | |||||||
gross profit | 174K - | -72K 141.38% | -80K 11.11% | 259K 423.75% | 636K 145.56% | 600K 5.66% | ||||||
selling and marketing expenses | ||||||||||||
general and administrative expenses | 1.41M - | 1.56M 11.10% | 1.25M 19.92% | 1.88M 50.40% | 1.61M 14.36% | 1.19M 26.09% | 1.13M 5.46% | 562K 50.04% | 586K 4.27% | 1.32M 125.43% | ||
selling general and administrative expenses | 1.41M - | 1.56M 11.10% | 1.25M 19.92% | 1.88M 50.40% | 1.61M 14.36% | 1.19M 26.09% | 1.13M 5.46% | 562K 50.04% | 586K 4.27% | 1.32M 125.43% | 2.60M 96.82% | |
research and development expenses | 5.61M - | 2.14M 61.94% | 12.56M 488.06% | 17.00M 35.37% | 4.90M 71.19% | 4.29M 12.33% | 744K 82.68% | 1.70M 128.23% | 4.93M 190.22% | 1.11M 77.54% | 1.50M 35.50% | |
other expenses | 1.66M - | 5.15M 209.74% | 128K 97.52% | 1.74M 1,260.16% | 655K 62.38% | 708K 8.09% | 697K 1.55% | 2.32M 232.42% | ||||
cost and expenses | 9.81M - | 6.07M 38.12% | 15.47M 154.97% | 24.04M 55.33% | 6.64M 72.39% | 7.23M 8.87% | 2.52M 65.07% | 2.97M 17.59% | 6.63M 123.28% | 9.36M 41.26% | 8.10M 13.47% | |
operating expenses | 9.81M - | 6.07M 38.12% | 15.47M 154.97% | 24.04M 55.33% | 6.64M 72.39% | 7.23M 8.87% | 2.52M 65.07% | 2.97M 17.59% | 6.21M 109.27% | 4.75M 23.60% | 4.10M 13.59% | |
interest expense | 210K - | 918K 337.14% | 1.22M 32.57% | 1.26M 3.29% | 167K 86.71% | 350K - | 95K 72.86% | 8K 91.58% | 61K 662.50% | 300K 391.80% | ||
ebitda | -7.33M - | -5.33M 27.28% | -15.37M 188.11% | -23.57M 53.41% | -4.77M 79.78% | -5.55M 16.43% | 2.25M 140.57% | -1.86M 182.81% | -5.70M 205.53% | -4.01M 29.59% | -7M 74.56% | |
operating income | -9.81M - | -6.07M 38.12% | -15.47M 154.97% | -24.04M 55.33% | -6.64M 72.39% | -7.05M 6.25% | 2.24M 131.74% | -2.97M 232.62% | -5.95M 100.54% | -4.11M 30.96% | -3.50M 14.82% | |
depreciation and amortization | 156K - | 88K 43.59% | 56K 36.36% | 48K 14.29% | 43K 10.42% | 39K 9.30% | 13K 66.67% | 1.10M 8,392.31% | 257K 76.72% | 99K 61.48% | -3.50M 3,635.35% | |
total other income expenses net | 2.11M - | -531K 125.19% | -1.16M 119.21% | -841K 27.75% | 1.66M 297.50% | 748K 54.97% | -350K 146.79% | 1.08M 409.14% | 130K 87.99% | -97K 174.62% | 3.50M 3,708.25% | |
income before tax | -7.70M - | -6.60M 14.29% | -16.64M 152.09% | -24.88M 49.51% | -4.98M 80.00% | -6.30M 26.69% | 1.89M 129.95% | -1.89M 199.89% | -5.82M 208.70% | -4.21M 27.76% | ||
income tax expense | 42K - | -37K 188.10% | 53K 243.24% | -5K 109.43% | 2K 140% | 1K 50% | 38K 3,700% | -617K 1,723.68% | 8K 101.30% | 97K 1,112.50% | 3.50M 3,508.25% | |
net income | -7.74M - | -6.56M 15.23% | -16.64M 153.51% | -24.87M 49.48% | -4.98M 79.98% | -6.30M 26.66% | 1.85M 129.33% | -1.89M 202.00% | -5.83M 209.12% | -4.30M 26.19% | -3.50M 18.66% | |
weighted average shs out | 13.16M - | 13.16M 0% | 16.63M 26.37% | 17.91M 7.67% | 18.25M 1.93% | 19.62M 7.51% | 20.60M 4.97% | 22.51M 9.27% | 24.88M 10.54% | 27.97M 12.41% | 31.82M 13.77% | |
weighted average shs out dil | 13.16M - | 13.16M 0% | 16.63M 26.37% | 19.39M 16.59% | 19.04M 1.83% | 19.62M 3.09% | 21.12M 7.63% | 22.51M 6.57% | 24.88M 10.54% | 27.97M 12.41% | 31.82M 13.77% | |
eps | -0.59 - | -0.50 15.25% | -1 100% | -1.39 39.00% | -0.27 80.58% | -0.32 18.52% | 0.09 128.06% | -0.08 193.32% | -0.23 174.46% | -0.15 34.78% | -0.11 26.67% | |
epsdiluted | -0.59 - | -0.50 15.25% | -1 100% | -1.28 28.00% | -0.26 79.69% | -0.32 23.08% | 0.09 127.34% | -0.08 195.77% | -0.23 174.46% | -0.15 34.78% | -0.11 26.67% |
All numbers in EUR (except ratios and percentages)